Cargando…
Investigating Community Pharmacy Take Home Naloxone Dispensing during COVID-19: The Impact of One Public Health Crisis on Another
A recent report found that the number of opioid-related deaths in Ontario in the first 15 weeks of the COVID-19 pandemic was 38.2% higher than in the 15 weeks before the pandemic. Our study sought to determine if pharmacy professionals self-reported an increase or decrease in naloxone provision due...
Autores principales: | Daskalakis, George, Cid, Ashley, Grindrod, Kelly, Beazely, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396297/ https://www.ncbi.nlm.nih.gov/pubmed/34449716 http://dx.doi.org/10.3390/pharmacy9030129 |
Ejemplares similares
-
What Is Known about Community Pharmacy-Based Take-Home Naloxone Programs and Program Interventions? A Scoping Review
por: Cid, Ashley, et al.
Publicado: (2021) -
Protocol for the Optimizing Naloxone Dispensing in Pharmacies (ONDP) Online Continuing Education Program: A Randomized Controlled Trial
por: Cid, Ashley, et al.
Publicado: (2022) -
Increasing proactive co-dispensing of take-home naloxone with prescription opioids at Ontario community pharmacies
por: Qiu Hua Chen, Autumn
Publicado: (2022) -
The status of naloxone in community pharmacies across Canada
por: So, Randy, et al.
Publicado: (2020) -
Vital Signs: Pharmacy-Based Naloxone Dispensing — United States, 2012–2018
por: Guy, Gery P., et al.
Publicado: (2019)